최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.29 no.3 = no.227, 2019년, pp.295 - 302
곽아원 (목포대학교 약학대학) , 윤구 (목포대학교 약학대학) , 채정일 (전북대학교 치과대학) , 심정현 (목포대학교 약학대학)
Liquiritigenin (LG) is a chiral flavonoid isolated from the roots of licorice. It exhibits multiple biological activities including anti-oxidant, anti-cancer, and anti-inflammatory effects. In particular though, the anti-cancer activity of LG in oral squamous cell carcinoma has yet to be elucidated,...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
LG가 가진 생화학적 기능들은 무엇인가? | 천연물인 감초에서 추출한 Liquiritigenin (LG)은 플라보노이드 구성원이다[21]. LG는 항암, 항산화, 항염증, 항고지혈증 및 항알레르기작용을 포함하여 다양한 생화학적 활성을 가지고 있다[1, 37]. LG는 포유류 세포주에서 세포사멸을 통한 항 종양 활성을 나타낸다는 연구 결과가 있다[14, 21, 37]. | |
Liquiritigenin (LG)은 무엇인가? | Liquiritigenin (LG)은 licorice 뿌리에서 분리된 chiral flavonoid이다. LG는 항산화, 항암 및 항염증 효과를 포함하여 다양한 생물학적 활성을 가지고 있다. | |
구강편평세포암종에서 LG의 항암 활성을 확인한 결과, 세포주기에 어떤 영향을 주었으며 이에 어떤 유전자 발현에 변화를 보였는가? | HN22 세포에 LG를 처리하여 MTT 분석으로 세포 생존율을 평가하였으며, Annecin V/7-Aminactinomycin D 염색, 세포주기 및 Multi-caspase 활성을 $Muse^{TM}$ cell Analyzer로 분석하여 세포사멸 유도를 확인하였다. 분석결과, 구강편평상피암 HN22 세포에 LG를 처리시 G2/M 세포주기 정지를 일으켰으며, Western blotting 통하여 cyclin B1 및 CDC2 발현 감소와 p27 발현 증가를 확인하였다. LG는 활성산소종의 생성을 유발하고, CCAAT/enhancer-binding protein homologous protein (CHOP) 및 78-kDa glucose regulated protein (GRP78)의 발현을 농도의존적으로 유도하였다. |
Alrushaid, S., Davies, N. M., Martinez, S. E. and Sayre, C. L. 2016. Pharmacological characterization of Liquiritigenin, a chiral flavonoid in licorice. Res. Pharm. Sci. 11, 355-365.
Ariyasu, D., Yoshida, H. and Hasegawa, Y. 2017. Endoplasmic Reticulum (ER) stress and endocrine disorders. Int. J. Mol. Sci. 18.
Belmokhtar, C. A., Hillion, J. and Segal-Bendirdjian, E. 2001. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20, 3354-3362.
Bundela, S., Sharma, A. and Bisen, P. S. 2014. Potential therapeutic targets for oral cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70. PLoS One 9, e102610.
Chen, J. 2016. The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harb. Perspect. Med. 6, a026104.
Degli Esposti, M. and Dive, C. 2003. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem. Biophys. Res. Commun. 304, 455-461.
Dickinson, B. C. and Chang, C. J. 2011. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 7, 504-511.
Fulda, S. and Debatin, K. M. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811.
Ge, G., Yan, Y. and Cai, H. 2017. Ginsenoside Rh2 inhibited proliferation by inducing ROS Mediated ER stress dependent apoptosis in lung cancer cells. Biol. Pharm. Bull. 40, 2117-2124.
Green, D. R. and Kroemer, G. 2004. The pathophysiology of mitochondrial cell death. Science 305, 626-629.
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y. and Sakuragi, N. 2014. Apoptosis and molecular targeting therapy in cancer. Biomed. Res. Int. 2014, 150845.
Hata, A. N., Engelman, J. A. and Faber, A. C. 2015. The BCL2 Family: Key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 5, 475-487.
Huang, C. H. and Chan, W. H. 2017. Protective effects of Liquiritigenin against citrinin-triggered, oxidative-stressmediated apoptosis and disruption of embryonic development in mouse blastocysts. Int. J. Mol. Sci. 18, pii:E2538.
Kardeh, S., Ashkani-Esfahani, S. and Alizadeh, A. M. 2014. Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur. J. Pharmacol. 735, 150-168.
Kishimoto, K., Yoshida, S., Ibaragi, S., Yoshioka, N., Hu, G. F. and Sasaki, A. 2014. Neamine inhibits oral cancer progression by suppressing angiogenin-mediated angiogenesis and cancer cell proliferation. Anticancer Res. 34, 2113-2121.
Kumar, M., Nanavati, R., Modi, T. G. and Dobariya, C. 2016. Oral cancer: Etiology and risk factors: A review. J. Cancer Res. Ther. 12, 458-463.
Lee, S. H., Meng, X. W., Flatten, K. S., Loegering, D. A. and Kaufmann, S. H. 2013. Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm. Cell Death Differ. 20, 64-76.
Leibowitz, B. and Yu, J. 2010. Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol. Ther. 9, 417-422.
Liu, C., Wang, Y., Xie, S., Zhou, Y., Ren, X., Li, X. and Cai, Y. 2011. Liquiritigenin induces mitochondria-mediated apoptosis via cytochrome c release and caspases activation in HeLa Cells. Phytother. Res. 25, 277-283.
Liu, Y., Xie, S., Wang, Y., Luo, K., Wang, Y. and Cai, Y. 2012. Liquiritigenin inhibits tumor growth and vascularization in a mouse model of HeLa cells. Molecules 17, 7206-7216.
Lu, W., Feng, F., Xu, J., Lu, X., Wang, S., Wang, L., Lu, H., Wei, M., Yang, G., Wang, L., Lu, Z., Liu, Y. and Lei, X. 2014. QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2. Cancer Biol. Ther. 15, 1174-1184.
Ma, Y., Zhang, J., Zhang, Q., Chen, P., Song, J., Yu, S., Liu, H., Liu, F., Song, C., Yang, D. and Liu, J. 2014. Adenosine induces apoptosis in human liver cancer cells through ROS production and mitochondrial dysfunction. Biochem. Biophys. Res. Commun. 448, 8-14.
Mersereau, J. E., Levy, N., Staub, R. E., Baggett, S., Zogovic, T., Chow, S., Ricke, W. A., Tagliaferri, M., Cohen, I., Bjeldanes, L. F. and Leitman, D. C. 2008. Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist. Mol. Cell Endocrinol. 283, 49-57.
Mills, C. C., Kolb, E. A. and Sampson, V. B. 2017. Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer. Cancer Res. 77, 6489-6498.
Mukherjee, A. K., Basu, S., Sarkar, N. and Ghosh, A. C. 2001. Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 8, 1467-1486.
Oh, H., Yoon, G., Shin, J. C., Park, S. M., Cho, S. S., Cho, J. H., Lee, M. H., Liu, K., Cho, Y. S., Chae, J. I. and Shim, J. H. 2016. Licochalcone B induces apoptosis of human oral squamous cell carcinoma through the extrinsic- and intrinsic-signaling pathways. Int. J. Oncol. 48, 1749-1757.
Oh, H. N., Seo, J. H., Lee, M. H., Kim, C., Kim, E., Yoon, G., Cho, S. S., Cho, Y. S., Choi, H. W., Shim, J. H. and Chae, J. I. 2018. Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway. J. Cell Biochem. 119, 10118-10130.
Oh, H. N., Seo, J. H., Lee, M. H., Yoon, G., Cho, S. S., Liu, K., Choi, H., Oh, K. B., Cho, Y. S., Kim, H., Han, A. L., Chae, J. I. and Shim, J. H. 2018. Oridonin induces apoptosis in oral squamous cell carcinoma probably through the generation of reactive oxygen species and the p38/JNK MAPK pathway. Int. J. Oncol. 52, 1749-1759.
Passante, E., Wurstle, M. L., Hellwig, C. T., Leverkus, M. and Rehm, M. 2013. Systems analysis of apoptosis protein expression allows the case-specific prediction of cell death responsiveness of melanoma cells. Cell Death Differ. 20, 1521-1531.
Shimizu, S., Narita, M. and Tsujimoto, Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487.
Simon, H. U., Haj-Yehia, A. and Levi-Schaffer, F. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418.
Singh, S. K., Banerjee, S., Acosta, E. P., Lillard, J. W. and Singh, R. 2017. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget 8, 17216-17228.
Taylor, W. R. and Stark, G. R. 2001. Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815.
Vilen, S. T., Salo, T., Sorsa, T. and Nyberg, P. 2013. Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013, 920595.
Wang, D., Lu, J., Liu, Y., Meng, Q., Xie, J., Wang, Z. and Teng, L. 2014. Liquiritigenin induces tumor cell death through mitogen-activated protein kinase- (MPAKs-) mediated pathway in hepatocellular carcinoma cells. Biomed. Res. Int. 2014, 965316.
Wang, D., Wong, H. K., Feng, Y. B. and Zhang, Z. J. 2014. Liquiritigenin exhibits antitumour action in pituitary adenoma cells via Ras/ERKs and ROS-dependent mitochondrial signalling pathways. J. Pharm. Pharmacol. 66, 408-417.
Wong, R. S. 2011. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30, 87.
Yuan, X., Li, T., Xiao, E., Zhao, H., Li, Y., Fu, S., Gan, L., Wang, Z., Zheng, Q. and Wang, Z. 2014. Licochalcone B inhibits growth of bladder cancer cells by arresting cell cycle progression and inducing apoptosis. Food Chem. Toxicol. 65, 242-251.
Zheng, Y. Z., Cao, Z. G., Hu, X. and Shao, Z. M. 2014. The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer. Breast Cancer Res. Treat. 145, 349-358.
Zhou, Y., Wang, K., Zhen, S., Wang, R. and Luo, W. 2016. Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21 (Waf1/Cip1) and p27(Kip1). Taiwan J. Obstet. Gynecol. 55, 847-851.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.